J9206 Irinotecan injection
Also known as: irinotecan, Camptosar
Intravenous injection of irinotecan, a semisynthetic topoisomerase I inhibitor chemotherapy.
In Plain Language
DNA-damaging cancer drug; colon cancer chemotherapy
Clinical Context
Used for metastatic colorectal cancer and other solid tumors.
RVU Information
CPT J9206 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9206?
CPT J9206 (Irinotecan injection) is a J Codes (Drugs) code. Intravenous injection of irinotecan, a semisynthetic topoisomerase I inhibitor chemotherapy.
How is J9206 administered?
CPT J9206 is administered by a healthcare provider, typically via injection or infusion. Used for metastatic colorectal cancer and other solid tumors. It is used by Oncology, Medical Oncology.
When is CPT J9206 used?
Used for metastatic colorectal cancer and other solid tumors.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.